Compensation Agreements in the Pharmaceuticals Industry
614 Contracts & Agreements
- ACELRX PHARMACEUTICALS INC (7 contracts)
- ACHILLION PHARMACEUTICALS INC (3)
- Aclaris Therapeutics, Inc. (11)
- Adamis Pharmaceuticals Corp (1)
- Aegerion Pharmaceuticals, Inc. (9)
- AEON Biopharma, Inc. (1)
- AERIE PHARMACEUTICALS INC (1)
- Akorn (1)
- ALDER BIOPHARMACEUTICALS INC (1)
- Alexza Pharmaceuticals Inc. (1)
- ALIMERA SCIENCES INC (18)
- ALSERES PHARMACEUTICALS INC (10)
- Altus Pharmaceuticals Inc. (3)
- Amag Pharmaceuticals (12)
- Amneal Pharmaceuticals, Inc. (6)
- Amphastar Pharma (1)
- AMYLIN PHARMACEUTICALS INC (2)
- Amylyx Pharmaceuticals, Inc. (2)
- AN2 Therapeutics, Inc. (1)
- Anebulo Pharmaceuticals, Inc. (1)
- Angion Biomedica Corp. (5)
- ANI Pharma Inc (7)
- Anthera Pharmaceuticals Inc (4)
- APP Pharmaceuticals, Inc. (2)
- APRICUS BIOSCIENCES, INC. (6)
- Aquestive Therapeutics, Inc. (1)
- ARIAD PHARMACEUTICALS INC (11)
- Aspreva Pharmaceuticals CORP (1)
- Assertio Holdings, Inc. (1)
- Assertio Therapeutics, Inc (3)
- Atea Pharmaceuticals, Inc. (3)
- Athira Pharma, Inc. (2)
- Auspex Pharmaceuticals, Inc. (4)
- AUXILIUM PHARMACEUTICALS INC (9)
- AVANIR PHARMACEUTICALS, INC. (2)
- Axsome Therapeutics, Inc. (1)
- BARR PHARMACEUTICALS INC (2)
- Bausch Health Companies Inc. (1)
- Biofrontera Inc. (1)
- Blue Water Acquisition Corp. (1)
- Bright Green Corp (1)
- Bristol-Myers Squibb (6)
- CADENCE PHARMACEUTICALS INC (3)
- CALLISTO PHARMACEUTICALS INC (2)
- Canopy Growth Corp (3)
- Cara Therapeutics, Inc. (5)
- CARDAX, INC. (2)
- CASSAVA SCIENCES INC (4)
- Catalent Inc (5)
- Cerecor Inc. (2)
- CHIASMA, INC (2)
- Clearside Biomedical, Inc. (4)
- Clever Leaves Holdings Inc. (1)
- CNS Pharmaceuticals, Inc. (3)
- COLLAGENEX PHARMACEUTICALS INC (6)
- CoLucid Pharmaceuticals, Inc. (2)
- CUBIST PHARMACEUTICALS INC (3)
- CUMBERLAND PHARMACEUTICALS INC (1)
- CymaBay Therapeutics, Inc. (6)
- Dova Pharmaceuticals Inc. (2)
- DUSA PHARMACEUTICALS INC (3)
- Edgewise Therapeutics, Inc. (2)
- Egalet Corp (1)
- Eleison Pharmaceuticals Inc (1)
- Endo International plc (2)
- EPIX Pharmaceuticals, Inc. (1)
- Evofem Biosciences, Inc. (5)
- Evoke Pharma Inc (10)
- EYENOVIA, INC. (3)
- Foamix Pharmaceuticals Ltd. (1)
- Fulcrum Therapeutics, Inc. (3)
- GB SCIENCES INC (1)
- GUILFORD PHARMACEUTICALS INC (1)
- Harmony Biosciences Holdings, Inc. (1)
- Horizon Pharma plc (11)
- IDENIX PHARMACEUTICALS INC (2)
- Ikena Oncology, Inc. (1)
- IMARA Inc. (2)
- INNOVATE BIOPHARMACEUTICALS, INC. (2)
- INSPIRE PHARMACEUTICALS INC (10)
- IntelGenx Technologies Corp. (1)
- Intersect ENT, Inc. (6)
- Intra-Cellular Therapies, Inc. (8)
- Iterum Therapeutics plc (2)
- Jazz Pharmaceuticals plc (21)
- Johnson & Johnson (9)
- Journey Medical Corp (1)
- KEMPHARM, INC (9)
- KING PHARMACEUTICALS INC (7)
- KOS PHARMACEUTICALS INC (2)
- Landos Biopharma, Inc. (1)
- Lannett Company, Inc. (1)
- Level Brands, Inc. (1)
- Lexaria Bioscience Corp. (1)
- Lilly (Eli) & Co. (7)
- Longboard Pharmaceuticals, Inc. (2)
- Lyra Therapeutics, Inc. (1)
- MedMen Enterprises, Inc. (1)
- Menlo Therapeutics Inc. (1)
- Merck (7)
- Milestone Pharmaceuticals Inc. (4)
- MILLENNIUM PHARMACEUTICALS INC (1)
- Mind Medicine (MindMed) Inc. (2)
- MJ Holdings, Inc. (1)
- MyoKardia Inc (4)
- NEKTAR THERAPEUTICS (11)
- Neos Therapeutics, Inc. (2)
- Neuralstem, Inc. (1)
- NEW RIVER PHARMACEUTICALS INC (2)
- NGM BIOPHARMACEUTICALS INC (3)
- NovaBay Pharmaceuticals, Inc. (10)
- Novan, Inc. (8)
- NOVEN PHARMACEUTICALS INC (1)
- NPS PHARMACEUTICALS INC (3)
- NUCRYST Pharmaceuticals Corp. (1)
- OMEROS CORP (4)
- OncoMed Pharmaceuticals Inc (5)
- ONYX PHARMACEUTICALS INC (3)
- OSI PHARMACEUTICALS INC (1)
- OTONOMY, INC. (1)
- Pacira Pharmaceuticals, Inc. (2)
- Panacea Acquisition Corp (2)
- PANACOS PHARMACEUTICALS, INC. (7)
- Paratek Pharmaceuticals, Inc. (12)
- PENWEST PHARMACEUTICALS CO (3)
- Perrigo (5)
- Pfizer (18)
- Phathom Pharmaceuticals, Inc. (5)
- PLIANT THERAPEUTICS, INC. (5)
- PRAECIS PHARMACEUTICALS INC (1)
- PREDIX PHARMACEUTICALS HOLDINGS INC (1)
- Prestige Brands Holdings Inc (2)
- ProPhase Labs, Inc. (12)
- Pulmatrix, Inc. (1)
- Ra Pharmaceuticals, Inc. (2)
- Rani Therapeutics Holdings, Inc. (1)
- REATA PHARMACEUTICALS INC (6)
- Recro Pharma, Inc. (1)
- resTORbio, Inc. (2)
- Revance Therapeutics, Inc. (10)
- Rib-X Pharmaceuticals, Inc. (1)
- Sagent Pharmaceuticals, Inc. (1)
- SALIX PHARMACEUTICALS LTD (2)
- Satsuma Pharmaceuticals, Inc. (1)
- scPharmaceuticals Inc. (1)
- SCYNEXIS INC (9)
- Sienna Biopharmaceuticals, Inc. (2)
- Strongbridge Biopharma plc (4)
- Sucampo Pharmaceuticals, Inc. (3)
- SUNWIN STEVIA INTERNATIONAL, INC. (2)
- TAPESTRY PHARMACEUTICALS, INC (1)
- Targeted Medical Pharma, Inc. (1)
- Terns Pharmaceuticals, Inc. (3)
- TEVA PHARMACEUTICAL INDUSTRIES LTD (1)
- The Medicines Company (4)
- TherapeuticsMD, Inc. (2)
- Theseus Pharmaceuticals, Inc. (2)
- Trevi Therapeutics, Inc. (2)
- Tribute Pharmaceuticals Canada Inc. (1)
- Vallon Pharmaceuticals, Inc. (2)
- Verrica Pharmaceuticals Inc. (4)
- VioQuest Pharmaceuticals, Inc. (1)
- Vitae Pharmaceuticals, Inc (1)
- Vyrix Pharmaceuticals, Inc. (1)
- Wave Life Sciences Ltd. (7)
- XANODYNE PHARMACEUTICALS INC (1)
- XERIS PHARMACEUTICALS INC (1)
- Zoetis (2)
- ZOGENIX, INC. (8)
- Zomedica Pharmaceuticals Corp. (1)
- Zynerba Pharmaceuticals, Inc. (2)
- Non-Employee Director Compensation Policy (SCYNEXIS INC, Filed With SEC on March 28, 2024)
- 2024 Non-Employee Director Compensation Plan (NovaBay Pharmaceuticals, Inc., Filed With SEC on March 26, 2024)
- Outside Director Compensation Policy, as amended February 13, 2024 (IMARA Inc., Filed With SEC on March 14, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (scPharmaceuticals Inc., Filed With SEC on March 13, 2024)
- Non-Employee Director Compensation Policy (Menlo Therapeutics Inc., Filed With SEC on March 1, 2024)
- Second Amended and Restated Non-Employee Director Compensation Policy, adopted by the Board as of February 27, 2024 (Verrica Pharmaceuticals Inc., Filed With SEC on February 29, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (PLIANT THERAPEUTICS, INC., Filed With SEC on February 27, 2024)
- Amendment No. 4 to Amended and Restated Deferred Compensation Plan (Pfizer, Filed With SEC on February 22, 2024)
- Non-Employee Director Compensation Program (CymaBay Therapeutics, Inc., Filed With SEC on January 26, 2024)
- Amended and Restated Non-Employee Director Compensation Program (Vallon Pharmaceuticals, Inc., Filed With SEC on December 4, 2023)
- Johnson & Johnson Deferred Compensation Plan (Johnson & Johnson, Filed With SEC on November 27, 2023)
- Non-Employee Director Compensation Program (Angion Biomedica Corp., Filed With SEC on November 13, 2023)
- Non-Employee Director Compensation Policy, as amended (Milestone Pharmaceuticals Inc., Filed With SEC on November 13, 2023)
- Non-Employee Director Compensation Policy, effective as of August 7, 2023 (Wave Life Sciences Ltd., Filed With SEC on November 9, 2023)
- Ninth Amended and Restated Non-Employee Director Compensation Policy (KEMPHARM, INC, Filed With SEC on August 14, 2023)
- Amendment and Restated Non-Employee Director Compensation Program (Phathom Pharmaceuticals, Inc., Filed With SEC on August 10, 2023)
- Amended and Restated Outside Director Compensation Policy (Theseus Pharmaceuticals, Inc., Filed With SEC on August 10, 2023)
- Non-Employee Director Compensation Policy, as Amended and Restated Effective February 8, 2023 (Evoke Pharma Inc, Filed With SEC on August 10, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (approved May 4, 2023) (Jazz Pharmaceuticals plc, Filed With SEC on August 9, 2023)
- Non-Employee Director Compensation Program (Atea Pharmaceuticals, Inc., Filed With SEC on August 8, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (Cara Therapeutics, Inc., Filed With SEC on August 7, 2023)
- Non-Employee Director Compensation Policy, as amended and restated May 25, 2023 (Longboard Pharmaceuticals, Inc., Filed With SEC on August 3, 2023)
- Non-Employee Director Compensation Policy, amended as of June 8, 2023 (Mind Medicine (MindMed) Inc., Filed With SEC on August 3, 2023)
- Cassava Sciences Non-Employee Director Compensation Plan (CASSAVA SCIENCES INC, Filed With SEC on August 3, 2023)
- CANOPY GROWTH CORPORATION NON-EMPLOYEE DIRECTOR COMPENSATION TABLE As of June 19, 2023 (Canopy Growth Corp, Filed With SEC on June 22, 2023)
- Non-Employee Director Compensation Policy, as Amended and Restated Effective February 8, 2023 (Evoke Pharma Inc, Filed With SEC on May 15, 2023)
- Amended and Restated Outside Director Compensation Policy (Edgewise Therapeutics, Inc., Filed With SEC on May 11, 2023)
- Ninth Amended and Restated Non-Employee Director Compensation Policy (Aclaris Therapeutics, Inc., Filed With SEC on May 8, 2023)
- Non-Employee Director Compensation Policy, as amended (Intra-Cellular Therapies, Inc., Filed With SEC on May 4, 2023)
- Non-Employee Director Compensation Policy (NGM BIOPHARMACEUTICALS INC, Filed With SEC on May 4, 2023)
- 2023 Non-Employee Director Compensation Plan (NovaBay Pharmaceuticals, Inc., Filed With SEC on March 31, 2023)
- Non-Employee Director Compensation Policy (Novan, Inc., Filed With SEC on March 30, 2023)
- Form of Option Agreement pursuant to 2022 Directors Equity Compensation Plan (ProPhase Labs, Inc., Filed With SEC on March 29, 2023)
- Non-Employee Director Compensation Policy, as amended (Milestone Pharmaceuticals Inc., Filed With SEC on March 29, 2023)
- Non-Employee Director Compensation Policy (Amylyx Pharmaceuticals, Inc., Filed With SEC on March 21, 2023)
- Omeros Corporation Non-Employee Director Compensation Policy (OMEROS CORP, Filed With SEC on March 13, 2023)
- Non-Employee Director Compensation Policy (APRICUS BIOSCIENCES, INC., Filed With SEC on March 10, 2023)
- NonEmployee Director Compensation and Grant Policy (Assertio Holdings, Inc., Filed With SEC on March 8, 2023)
- EighthAmended and Restated Non-Employee Director Compensation Policyeffective February 15, 2023 (KEMPHARM, INC, Filed With SEC on March 7, 2023)
- Outside Director Compensation Policy (IMARA Inc., Filed With SEC on March 1, 2023)
